![Alex Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: - $ am 30.06.2026
Alex Wilson currently works at AEON Biopharma, Inc. as Secretary, Chief Legal Officer & Executive VP since 2021.
Formerly, Mr. Wilson worked at Glaukos Corp.
as Associate General Counsel & Business Development and at O'Melveny & Myers LLP as Head-Counsel.
Education includes undergraduate studies at Brigham Young University and graduate studies at UCLA School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.04.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AEON BIOPHARMA, INC. | General Counsel | 01.08.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| GLAUKOS CORPORATION | Corporate Officer/Principal | 01.08.2021 |
O'Melveny & Myers LLP
 O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
O'Melveny & Myers LLP
O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA School of Law
 UCLA School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AEON Biopharma, Inc.
 AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
